Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chauhan

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Plant Biotechnology Journal|December 2, 2017
Provitamin A biofortification of cassava enhances shelf life but reduces dry matter content of storage roots due to altered carbon partitioning into starchGetu Beyene, Felix R Solomon, Raj D Chauhan, et al.
Leukemia|June 8, 2017
Nucleotide excision repair is a potential therapeutic target in multiple myelomaR Szalat, M K Samur, M Fulciniti, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>C N Owen, A N Shoushtari, D Chauhan, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Plant Biotechnology Journal|December 2, 2017
Provitamin A biofortification of cassava enhances shelf life but reduces dry matter content of storage roots due to altered carbon partitioning into starchGetu Beyene, Felix R Solomon, Raj D Chauhan, et al.
Leukemia|June 8, 2017
Nucleotide excision repair is a potential therapeutic target in multiple myelomaR Szalat, M K Samur, M Fulciniti, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>C N Owen, A N Shoushtari, D Chauhan, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 15